Table:
Characteristic	ZSQ group (n = 42)	Control group (n = 42)	P value
Age, yr	32.7 ± 13.6	34.8 ± 14.3	0.46
Education, yr	10.5 ± 3.7	10.6 ± 3.9	0.35
BMI, kg/m2	22.1 ± 2.6	22.7 ± 3.1	0.44
Female (n, %)	39 (92.8%)	38 (90.48%)	0.67
Disease duration, yr	4.7 ± 4.4	5.0 ± 4.6	0.79
Dosage of prednisone, mg/d	10.2 ± 6.4	10.6 ± 6.6	0.62
SLEDAI scores	10.5 ± 2.2	10.7 ± 2.1	0.51
SLE manifestations (n, %)
Nephritis	32 (76.2%)	34 (81.0%)
Arthritis	20 (47.6%)	18 (42.9%)
Dermatitis	24 (57.1%)	21 (50.0%)	>0.05
Central nervous system	2 (4.8%)	1 (2.4%)
Lymphopenia	9 (21.4%)	8 (19.0%)
Thrombocytopenia	6 (14.3%)	7 (16.7%)
Pericarditis	1 (2.3%)	0 (0.0%)
Total scores of CMS	19.5 ± 3.9	19.7 ± 3.9	0.80
Anti-dsDNA (IU/mL)	89.8 ± 72.9	89.2 ± 80.5	0.63
C3 (g/L)	0.8 ± 0.3	0.8 ± 0.2	0.47
C4 (g/L)	0.2 ± 0.1	0.3 ± 0.1	0.61
IgG (g/L)	18.7 ± 5.4	17.9 ± 2.8	0.38
NK cell activity (%)	14.5 ± 8.8	14.0 ± 6.2	0.78
sIL-2R (pg/mL, PM)	40.8 ± 8.6	40.1 ± 14.8	0.80

What are the following picture content in markdown style: | Characteristic | ZSQ group (n = 42) | Control group (n = 42) | P value | 
 | --- | --- | --- | --- | 
 | Age, yr | 32.7 ± 13.6 | 34.8 ± 14.3 | 0.46 | 
 | Education, yr | 10.5 ± 3.7 | 10.6 ± 3.9 | 0.35 | 
 | BMI, kg/m2 | 22.1 ± 2.6 | 22.7 ± 3.1 | 0.44 | 
 | Female (n, %) | 39 (92.8%) | 38 (90.48%) | 0.67 | 
 | Disease duration, yr | 4.7 ± 4.4 | 5.0 ± 4.6 | 0.79 | 
 | Dosage of prednisone, mg/d | 10.2 ± 6.4 | 10.6 ± 6.6 | 0.62 | 
 | SLEDAI scores | 10.5 ± 2.2 | 10.7 ± 2.1 | 0.51 | 
 | SLE manifestations (n, %) |  |  |  | 
 | Nephritis | 32 (76.2%) | 34 (81.0%) |  | 
 | Arthritis | 20 (47.6%) | 18 (42.9%) | 

| 
 | Dermatitis | 24 (57.1%) | 21 (50.0%) | <ROWSPAN=2> >0.05 | 
 | Central nervous system | 2 (4.8%) | 1 (2.4%) | 
 | Lymphopenia | 9 (21.4%) | 8 (19.0%) |  | 
 | Thrombocytopenia | 6 (14.3%) | 7 (16.7%) |  | 
 | Pericarditis | 1 (2.3%) | 0 (0.0%) |  | 
 | Total scores of CMS | 19.5 ± 3.9 | 19.7 ± 3.9 | 0.80 | 
 | Anti-dsDNA (IU/mL) | 89.8 ± 72.9 | 89.2 ± 80.5 | 0.63 | 
 | C3 (g/L) | 0.8 ± 0.3 | 0.8 ± 0.2 | 0.47 | 
 | C4 (g/L) | 0.2 ± 0.1 | 0.3 ± 0.1 | 0.61 | 
 | IgG (g/L) | 18.7 ± 5.4 | 17.9 ± 2.8 | 0.38 | 
 | NK cell activity (%) | 14.5 ± 8.8 | 14.0 ± 6.2 | 0.78 | 
 | sIL-2R (pg/mL, PM) | 40.8 ± 8.6 | 40.1 ± 14.8 | 0.80 |